Related references
Note: Only part of the references are listed.Interference with ERK-dimerization at the nucleocytosolic interface targets pathological ERK1/2 signaling without cardiotoxic side-effects
Angela Tomasovic et al.
NATURE COMMUNICATIONS (2020)
The protective effect of piperine against isoproterenol-induced inflammation in experimental models of myocardial toxicity
Vijaya Padma Viswanadha et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
MG53, A Novel Regulator of KChIP2 and Ito,f, Plays a Critical Role in Electrophysiological Remodeling in Cardiac Hypertrophy
Wenjuan Liu et al.
CIRCULATION (2019)
Heat-shock protein 90 modulates cardiac ventricular hypertrophy via activation of MAPK pathway
Shoko Tamura et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2019)
The protective effect of high mobility group protein HMGA2 in pressure overload-induced cardiac remodeling
Qing-Qing Wu et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2019)
ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy
Simona Gallo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The P-selectin and PSGL-1 axis accelerates atherosclerosis via activation of dendritic cells by the TLR4 signaling pathway
Zhishuai Ye et al.
CELL DEATH & DISEASE (2019)
The Edwardsiella piscicida thioredoxin-like protein inhibits ASK1-MAPKs signaling cascades to promote pathogenesis during infection
Dahai Yang et al.
PLOS PATHOGENS (2019)
Calcium-induced dissociation of CIB1 from ASK1 regulates agonist-induced activation of the p38 MAPK pathway in platelets
Pravin Patel et al.
BIOCHEMICAL JOURNAL (2019)
Testin protects against cardiac hypertrophy by targeting a calcineurin-dependent signalling pathway
Lu Gao et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Therapeutic Value of ASK1 Inhibition in Pulmonary Arterial Hypertension
Olivier Boucherat et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
ASK1 Inhibition Halts Disease Progression in Preclinical Models of Pulmonary Arterial Hypertension
Grant R. Budas et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Betulinic acid attenuates dexamethasone-induced oxidative damage through the JNK-P38 MAPK signaling pathway in mice
Lijuan Zhu et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology
Maria G. Crespo-Leiro et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
The polypeptide N-acetylgalactosaminyltransferase 4 exhibits stage-dependent expression in colorectal cancer and affects tumorigenesis, invasion and differentiation
Xialin Yan et al.
FEBS JOURNAL (2018)
ASK1 inhibitor treatment suppresses p38/JNK signalling with reduced kidney inflammation and fibrosis in rat crescentic glomerulonephritis
Liv A. Amos et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Mechanisms of physiological and pathological cardiac hypertrophy
Michinari Nakamura et al.
NATURE REVIEWS CARDIOLOGY (2018)
Structural and Mechanistic Insights into the Catalytic-Domain-Mediated Short-Range Glycosylation Preferences of GalNAc-T4
Matilde de las Rivas et al.
ACS CENTRAL SCIENCE (2018)
Loss of N-Acetylgalactosaminyltransferase-4 Orchestrates Oncogenic MicroRNA-9 in Hepatocellular Carcinoma
Yidong Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates
Pi-Xiao Wang et al.
NATURE MEDICINE (2017)
Cardiac myocyte miR-29 promotes pathological remodeling of the heart by activating Wnt signaling
Yassine Sassi et al.
NATURE COMMUNICATIONS (2017)
Translocase of Inner Membrane 50 Functions as a Novel Protective Regulator of Pathological Cardiac Hypertrophy
Kai Tang et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy
Lantao Liu et al.
CARDIOVASCULAR RESEARCH (2016)
Cardiac contractility modulation: a novel approach for the treatment of heart failure
Freddy Abi-Samra et al.
HEART FAILURE REVIEWS (2016)
Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets
Yow Keat Tham et al.
ARCHIVES OF TOXICOLOGY (2015)
Thioredoxin-2 Inhibits Mitochondrial Reactive Oxygen Species Generation and Apoptosis Stress Kinase-1 Activity to Maintain Cardiac Function
Qunhua Huang et al.
CIRCULATION (2015)
Mechanotransduction in Cardiac Hypertrophy and Failure
Robert C. Lyon et al.
CIRCULATION RESEARCH (2015)
Angiogenesis and Cardiac Hypertrophy Maintenance of Cardiac Function and Causative Roles in Heart Failure
Toru Oka et al.
CIRCULATION RESEARCH (2014)
Control of mucin-type O-glycosylation: A classification of the polypeptide GalNAc-transferase gene family
Eric P. Bennett et al.
GLYCOBIOLOGY (2012)
Mitogen-Activated Protein Kinase Signaling in the Heart: Angels Versus Demons in a Heart-Breaking Tale
Beth A. Rose et al.
PHYSIOLOGICAL REVIEWS (2010)
ASK1 Regulates Cardiomyocyte Death but Not Hypertrophy in Transgenic Mice
Qinghang Liu et al.
CIRCULATION RESEARCH (2009)
Apoptosis signal-regulating kinase 1 attenuates atrial natriuretic peptide secretion
Xiaoyin Shan et al.
BIOCHEMISTRY (2008)
Thioredoxin and TRAF family proteins regulate reactive oxygen species-dependent activation of ASK1 through reciprocal modulation of the N-terminal homophilic interaction of ASK1
Go Fujino et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Small heat-shock protein Hsp20 attenuates β-agonist-mediated cardiac remodeling through apoptosis signal-regulating kinase 1
Guo-Chang Fan et al.
CIRCULATION RESEARCH (2006)
O-glycosylation in Toxoplasma gondii:: Identification and analysis of a family of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases
MM Stwora-Wojczyk et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2004)
Share Paper
